October 24, 2017Comments Off on Exploring Biosimilars as a Drug Patent Strategy Posted in: Insights
Biologic drugs are far more complex than traditional “small molecule” drugs Generic drugs as we know them differ from biosimilars, which are designed to be less costly alternatives to branded biologic drugs.…
The post Exploring Biosimilars as a Drug Patent Strategy appeared first on DrugPatentWatch - Make Better Decisions.
Comments are closed.
Get email updates
Get new actionable insights and updates from BiotechBlog